Haleon (HLN) Long-Term Debt Repayments (2022 - 2023)
Haleon (HLN) posted Long-Term Debt Repayments of -$304.1 million for Q4 2023, down 2256.82% on a QoQ basis from -$12.9 million in Q4 2022, and down 2256.82% year-over-year from $14.1 million in Q4 2022.
Haleon (HLN) Long-Term Debt Repayments (2022 - 2023) Analysis & Trends
Haleon's Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at -$304.1 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.82 Bn | 32.08 Bn | 1.97 Bn | 23.00 Mn |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.70 Bn | 23.64 Bn | 4.39 Bn | -478.39 Mn |
| 5 | United Therapeutics | 23.15 Bn | 21.00 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.16 Bn | 18.35 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.86 Bn | 16.55 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -304.08 Mn |
| Dec 31, 2023 | -304.08 Mn |
| Dec 31, 2022 | -12.90 Mn |
| Dec 31, 2022 | -12.90 Mn |